Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 157-163 , March 2010

Molecular biomarkers for advanced renal cell carcinoma: Implications for prognosis and therapy

  • Hyo Song Kim, M.D.

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • These two authors contributed equally to this work.
  • ,
  • Won Seog Kim, M.D.

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • ,
  • Se Hoon Park, M.D.

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • ,
  • Chul Won Jung, M.D.

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • ,
  • Han Yong Choi, M.D.

      Affiliations

    • Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • ,
  • Hyun Moo Lee, M.D.

      Affiliations

    • Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • ,
  • Seong Soo Jeon, M.D.

      Affiliations

    • Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • ,
  • Hongil Ha, M.D.

      Affiliations

    • National Institute of Scientific Investigation, Seoul, Korea
  • ,
  • In Gyu Hwang, M.D.

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, Chung-Ang University Yong San Hospital, Seoul, Korea
    • These two authors contributed equally to this work.
  • ,
  • Seungkoo Lee, M.D.

      Affiliations

    • Department of Anatomic Pathology, School of Medicine, Kangwon National University, Chunchon, Korea
  • ,
  • Ho Yeong Lim, M.D.

      Affiliations

    • Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82-2-3410-0914; fax: +82-2-3410-1754

Received 7 June 2008 ,Revised 7 August 2008 ,Accepted 7 August 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(08)00194-4

doi: 10.1016/j.urolonc.2008.08.002

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 2 , Pages 157-163 , March 2010